Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Acc...

Biomarkers Market Overview, Analysis and Increasing application of diagnostic application is expected to fuel growth of the global biomarkers market

Biomarkers are molecules that are used to diagnose diseases because they signal whether a process in the body is normal or abnormal. Biomarkers are any molecules, such as DNA (genes), proteins, or hormones, that provide information about one's health and can be classed based on a variety of factors, including imaging biomarkers and molecular biomarkers. Biomarkers are becoming more popular in the drug research and development process, as their application improves drug development success rates, lowers costs, and improves patient outcomes. Biomarkers can also help predict therapeutic efficacy more quickly than standard clinical endpoints.

Biomarkers are gaining traction in the creation of new products and the treatment of illnesses such as chromosomal structure, Turner syndrome, Down syndrome, and others, which is driving up demand for biomarkers. Banyan Biomarkers, Inc., for example, was granted marketing permission by the FDA in February 2018 for Banyan BTI, the first diagnostic blood test for traumatic brain injury. As a result, the introduction of such cutting-edge diagnostic tools for a variety of illness indications is expected to propel the biomarkers market forward over the forecast period.

 

Biomarkers Market
Biomarkers Market

Increasing application of diagnostic application is expected to fuel growth of the global biomarkers market

Growing application and awareness of biomarker tests is predicted to be a key driver of market expansion. Biomarkers are utilised instead of traditional diagnostic methods for diagnosing and early identification of specific diseases. Furthermore, biomarkers such as BRCA1 can determine whether a person is at a higher risk of acquiring cancer. Biomarkers are used in a range of therapeutic fields, including neurological diseases, metabolic disorders, immunological dysregulation, and oncology, to treat diseases include TMI, cancer, and Alzheimer's disease. Newborn ABO haemolytic disease, Huntington disease, inherited haemochromatosis, and cystic fibrosis are also detected using biomarkers.

Furthermore, biomarkers are utilised to diagnose chromosomal structural disorders like as Turner syndrome, Down syndrome, Patau syndrome, Edwards' syndrome, and others, leading to an increase in biomarker demand.

Comments

Popular posts from this blog

Future Prospects of Global Laboratory Proficiency Testing Market

Malaria Vaccines Market – Making Way for a Malaria-Free World

Global and China Catheter Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027